[UOADEV] YoY Annual (Unaudited) Result on 31-Dec-2017 [#4]

Stock
[UOADEV] UOA DEVELOPMENT BERHAD
Announcement Date
21-Feb-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Dec-2017 [#4]
Profit Trend
YoY- -27.42%
Quarter Report
Latest QR
Upcoming QR
UOADEV's Result
UOADEV's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 844,597 1,104,457 1,263,677 1,081,602 996,193 1,643,188 1,077,849 -3.97%
PBT 479,956 510,097 505,850 656,061 929,364 645,286 460,704 0.68%
Tax -80,223 -101,675 -94,252 -129,283 -218,726 -157,253 -103,864 -4.20%
NP 399,733 408,422 411,598 526,778 710,638 488,033 356,840 1.90%
-
NP to SH 391,288 399,474 378,916 491,182 676,726 417,016 316,122 3.61%
-
Tax Rate 16.71% 19.93% 18.63% 19.71% 23.54% 24.37% 22.54% -
Total Cost 444,864 696,035 852,079 554,824 285,555 1,155,155 721,009 -7.72%
-
Net Worth 5,415,616 5,072,339 4,683,094 4,280,790 3,817,347 3,048,104 2,651,613 12.62%
Dividend
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Div 318,565 275,243 258,123 259,967 244,701 220,877 179,536 10.01%
Div Payout % 81.41% 68.90% 68.12% 52.93% 36.16% 52.97% 56.79% -
Equity
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Net Worth 5,415,616 5,072,339 4,683,094 4,280,790 3,817,347 3,048,104 2,651,613 12.62%
NOSH 2,124,905 1,967,157 1,844,871 1,734,247 1,632,469 1,472,514 1,381,048 7.43%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 47.33% 36.98% 32.57% 48.70% 71.34% 29.70% 33.11% -
ROE 7.23% 7.88% 8.09% 11.47% 17.73% 13.68% 11.92% -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 39.77 56.18 68.54 62.41 61.07 111.59 78.05 -10.61%
EPS 19.34 21.07 21.26 29.26 43.07 28.32 22.89 -2.76%
DPS 15.00 14.00 14.00 15.00 15.00 15.00 13.00 2.41%
NAPS 2.55 2.58 2.54 2.47 2.34 2.07 1.92 4.83%
Adjusted Per Share Value based on latest NOSH - 1,734,247
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 32.18 42.08 48.14 41.21 37.95 62.60 41.06 -3.97%
EPS 14.91 15.22 14.44 18.71 25.78 15.89 12.04 3.62%
DPS 12.14 10.49 9.83 9.90 9.32 8.41 6.84 10.02%
NAPS 2.0632 1.9324 1.7841 1.6308 1.4543 1.1612 1.0102 12.62%
Price Multiplier on Financial Quarter End Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 -
Price 1.69 2.03 2.12 2.39 2.35 2.06 2.11 -
P/RPS 4.25 3.61 3.09 3.83 3.85 1.85 2.70 7.84%
P/EPS 9.17 9.99 10.32 8.43 5.67 7.27 9.22 -0.09%
EY 10.90 10.01 9.69 11.86 17.65 13.75 10.85 0.07%
DY 8.88 6.90 6.60 6.28 6.38 7.28 6.16 6.27%
P/NAPS 0.66 0.79 0.83 0.97 1.00 1.00 1.10 -8.15%
Price Multiplier on Announcement Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 24/02/21 26/02/20 05/03/19 21/02/18 22/02/17 25/02/16 25/02/15 -
Price 1.70 1.98 2.22 2.54 2.50 2.10 2.12 -
P/RPS 4.27 3.52 3.24 4.07 4.09 1.88 2.72 7.79%
P/EPS 9.23 9.74 10.80 8.96 6.03 7.42 9.26 -0.05%
EY 10.84 10.26 9.26 11.16 16.59 13.49 10.80 0.06%
DY 8.82 7.07 6.31 5.91 6.00 7.14 6.13 6.24%
P/NAPS 0.67 0.77 0.87 1.03 1.07 1.01 1.10 -7.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment